We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.48B
AUM Growth
-$421M
Cap. Flow
-$409M
Cap. Flow %
-11.76%
Top 10 Hldgs %
29.04%
Holding
2,570
New
615
Increased
414
Reduced
391
Closed
826

Sector Composition

Rank Sector Weight
1 Financials 14.01%
2 Technology 9.47%
3 Industrials 7.12%
4 Consumer Discretionary 4.8%
5 Healthcare 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLND.WS icon
1451
Southland Holdings Warrants
SLND.WS
$1.48M
$66K ﹤0.01%
+180,055
New +$78K
TARA icon
1452
Protara Therapeutics
TARA
$220M
$66K ﹤0.01%
12,872
-3,983
-24% -$20.9K
OSI.WS
1453
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$66K ﹤0.01%
275,000
BSKYW
1454
DELISTED
Big Sky Growth Partners, Inc. Warrant
BSKYW
$66K ﹤0.01%
150,000
TAST
1455
DELISTED
Carrols Restaurant Group, Inc.
TAST
$63K ﹤0.01%
27,992
EOCW.WS
1456
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$63K ﹤0.01%
105,225
TWO
1457
Two Harbors Investment
TWO
$1.26B
$62K ﹤0.01%
+2,783
New +$60.5K
ABOS icon
1458
Acumen Pharmaceuticals
ABOS
$178M
$61K ﹤0.01%
+15,600
New +$84.9K
OLMA icon
1459
Olema Pharmaceuticals
OLMA
$911M
$61K ﹤0.01%
+14,288
New +$78.7K
EMBK
1460
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$61K ﹤0.01%
+514
New +$49.8K
LIDR icon
1461
CALL
AEye
LIDR
$61.8M
$60K ﹤0.01%
367
WWR icon
1462
Westwater Resources
WWR
$76.3M
$60K ﹤0.01%
30,200
+2,800
+10% +$5.67K
ALGS icon
1463
Aligos Therapeutics
ALGS
$45.5M
$58K ﹤0.01%
+1,084
New +$86.8K
GEOS icon
1464
Geospace Technologies
GEOS
$69.2M
$58K ﹤0.01%
+10,058
New +$66.3K
BTMDW
1465
DELISTED
Biote Corp. Warrant
BTMDW
$58K ﹤0.01%
105,167
+42,667
+68% +$20.2K
BRIVW
1466
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$58K ﹤0.01%
116,666
GGGVR
1467
DELISTED
G3 VRM Acquisition Corp. Rights
GGGVR
$58K ﹤0.01%
275,000
TYGOW
1468
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
$54K ﹤0.01%
200,000
ADERW
1469
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$53K ﹤0.01%
+101,877
New +$48.9K
GHG
1470
GreenTree Hospitality
GHG
$113M
$50K ﹤0.01%
10,000
PSTX
1471
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$50K ﹤0.01%
+11,250
New +$50.7K
POWRW
1472
DELISTED
Powered Brands Warrants
POWRW
$50K ﹤0.01%
147,266
SHCR
1473
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$49K ﹤0.01%
+20,034
New +$65.8K
LHC.WS
1474
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$49K ﹤0.01%
143,866
+47,411
+49% +$23.3K
HIPO icon
1475
Hippo Holdings
HIPO
$881M
$48K ﹤0.01%
963
-511
-35% -$26.4K

Similar funds

Prelude Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Prelude Capital Management held 2,570 positions worth $3.48B, down 11% from $3.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management withdrew a net $409M in Q1 2022, closing 826 positions and reducing 391 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $25.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prelude Capital Management opened a new position in Screaming Eagle Acquisition Corp. Class A Ordinary Shares worth $16.1M.

  • Prelude Capital Management's largest Q1 2022 buy was Screaming Eagle Acquisition Corp. Class A Ordinary Shares: 1,651,600 shares worth $16.1M.
  • Prelude Capital Management added most to TSMC in Q1 2022, an estimated $29.8M increase.
  • Prelude Capital Management's biggest Q1 2022 reduction was Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant, cutting an estimated $6.05M.
  • Prelude Capital Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $25.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $3.48B portfolio in Q1 2022.
  • Prelude Capital Management opened 615 new positions and closed 826 in Q1 2022.
  • Prelude Capital Management's portfolio value fell 11% quarter-over-quarter to $3.48B.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.